Business Standard

This new drug could be a hope for mothers dying during childbirth

The ability of a drug to stanch bleeding is important, as India tries to improve on its 22% decline in maternal mortality ratio (MMR), from 167 in 2011-13 to 130 in 2014-16

One of the child birth photographs. Child birth photography, a hit among sections of people in the West, is yet to catch up in India.(Photo: PTI)
Premium

One of the child birth photographs. Child birth photography, a hit among sections of people in the West, is yet to catch up in India.(Photo: PTI)

Devanik Saha | IndiaSpend New Delhi
An improved version of the drug carbetocin could save Indian mothers who die due to postpartum haemorrhage–excessive bleeding during childbirth–according to a new study.
Currently, the World Health Organization (WHO) recommends oxytocin–a chemical cousin of carbetocin–to prevent excessive bleeding during childbirth, but oxytocin must be stored and transported at 2–8o C, which is hard to do in many countries, including India, depriving many women of access to this drug, said the WHO study, published in the

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in